EHC, US29261A1007

Encompass Health stock: Q3 revenue rises 8.9%

Published on 11/10/2026 at 00:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Encompass Health stock followed stronger third-quarter operating results. The rehabilitation operator is expanding its hospital and bed capacity.

Quarterly growth supports expansion plan

  • Third-quarter revenue and adjusted EBITDA increased year over year.
  • Higher discharges and same-store activity supported operating performance.
  • Encompass Health continues adding hospitals and beds to meet rehabilitation demand.
EHC, US29261A1007, Illustration mit AI erstellt.

Encompass Health reported stronger third-quarter operating results on October 28, 2026, according to the company's earnings release filed with the SEC filing. Net operating revenue rose 8.9 percent year over year to 1,609.5 million US dollars for the quarter ended September 30.

Encompass Health stock traded at 125.50 euros on Lang & Schwarz at 23:00 CET on Monday, November 9, 2026. The quote is a late-session indication and is not paired here with a verified Xetra closing comparison.

Operating momentum remained broad

Adjusted EBITDA increased 15.5 percent to 346.6 million US dollars, while adjusted earnings per share rose 23.6 percent to 1.52 US dollars. Cash flow from operating activities reached 362.0 million US dollars, up from 270.8 million US dollars in the year-earlier quarter.

Patient activity also strengthened. Discharges increased 5.7 percent to 69,605, same-store discharge growth was 3.0 percent, and net patient revenue per discharge rose 4.0 percent to 22,543 US dollars. The figures indicate that both volume and revenue per discharge contributed to the quarter's performance.

Capacity expansion stays central

Management said Encompass Health opened four hospitals totaling 189 beds during the first nine months of 2026 and added 85 beds at existing hospitals. The expansion is intended to address growing demand for inpatient rehabilitation, but new capacity also requires staffing, occupancy and reimbursement execution.

The company's investor-relations corporate overview says Encompass Health operates 179 inpatient rehabilitation hospitals in the United States. Its model combines physician oversight, round-the-clock nursing and multidisciplinary therapy, with growth focused on new hospitals and bed additions.

For investors, the combination of discharge growth, higher revenue per discharge and additional capacity provides the main operating framework for assessing the shares. Regulatory requirements, labor availability and reimbursement conditions remain important factors in converting expansion into sustained earnings growth.

Encompass Health at a glance

  • Company: Encompass Health Corporation
  • ISIN: US29261A1007
  • Ticker: EHC
  • Primary exchange: NYSE
  • Lang & Schwarz quote: 125.50 euros on November 9, 2026, at 23:00 CET
  • Industry: Hospitals and inpatient rehabilitation

The S&P 500 provides the broad US equity-market backdrop for investors assessing healthcare shares.

More news and analyses on Encompass Health stock

Disclaimer...
en | US29261A1007 | EHC | boerse | 70483412 | bgmi